Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Cervical Esophagus Adenocarcinoma

Carcinoma, Transitional Cell

Pancreatic Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Locally Advanced Rectal Cancer

Cholangiocarcinoma

Pancreatic Neoplasms, Neoplasms, Basal Cell

Lymphoma, Large B-Cell, Diffuse

Rectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Small Bowel Adenocarcinoma

Stomach Neoplasms

Locally Advanced Rectal Cancer

Pancreatic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Chemotherapy Effect

Neoplasms, Stomach Neoplasms

Pancreatic cancer, adult, Pancreatic Neoplasms

Hepatecellular Carcinoma

Pancreatic Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Biliary Tract Neoplasms Immunotherapy

Colorectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

LAP100

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

TORCH-iTNT

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

PANGEA

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma

SCOTI

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

TRIUNITE-08

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

TRIBE-C

PANCREAS

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

FOBEAR

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

SMART TNT

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

CAPRI-3 GOIM

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

PANC

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

CEIL

AIO-KRK-0418

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

TRIFLUOX-DP

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

AtezoTRIBE2

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE